Indian clinical investigators may be tempted to use patient-reported outcomes for research. But cultural differences with the west may pose…
The first epilepsy surgery in India was performed at Christian Medical College, Vellore in 1952 by Prof Jacob Chandy. Sixty-nine years later, it is quite disappointing that only 2 in 1000 eligible epilepsy surgery candidates get operated on every year in India today, creating a huge surgical treatment gap.
For a significant proportion of people, COVID-19 leads to medium- to long-term effects that can have a significant impact on the quality of life. Some symptoms may linger or recur for days, weeks or months following initial recovery, while some patients develop medical complications that may have lasting lifetime health effects.
Be always prepared for discouragements and disappointments that can pull you down in this profession. One should be aware that there are traps all around you, especially at a time when the organisational, social and political systems often turn hostile to committed services and endeavours.
India has followed a policy of price control of pharmaceutical products for long, and in recent times it has extended the ambit to include certain devices as well.
Today, medicine has become highly specialised and technology-driven, leading to the widespread use of medical devices as diagnostic and therapeutic healthcare tools. This has led to the rapid growth of the medical device industry.
The Alma Ata declaration of 1978, one of the most significant milestones in the field of public health, identified effective primary care as the very bedrock of a health system that aims for universal healthcare.
I believe this artificial intelligence is going to be our partner. If we misuse it, it will be a risk. If we use it right, it can be our partner.” – Masayoshi Son, Japanese business magnate.